Priapism
Showing 1 - 25 of 120
ManAgement of pRiapiSm and Its Impact on Outcomes
Enrolling by invitation
- Priapism
-
Catania, CT, Italy
- +4 more
Sep 27, 2022
Sickle Cell Disease, Dyslipidemia, Complication Trial in Pointe-à-Pitre, Le Lamentin (HDL2)
Recruiting
- Sickle Cell Disease
- +2 more
- HDL2
-
Pointe-à-Pitre, Guadeloupe, France
- +1 more
Mar 21, 2023
Sickle Cell Disease Trial in Créteil (Voxelotor 1500 mg oral per day (GBT440) for 48 weeks in patients with sickle-cell disease)
Not yet recruiting
- Sickle Cell Disease
- Voxelotor 1500 mg oral per day (GBT440) for 48 weeks in patients with sickle-cell disease
-
Créteil, FranceHospital Henri Mondor
Jan 5, 2022
Via Ischemia of Penis vs Rigiscan. A New Sensor-driven Device to
Completed
- Erectile Dysfunction
-
Nieuwegein, Utrecht, NetherlandsSt Antonius Hospital
Nov 16, 2022
Sleep Initiation and Maintenance Disorders Trial (QUALI)
No longer available
- Sleep Initiation and Maintenance Disorders
- (no location specified)
Feb 23, 2023
Retrospective Real World Oxbryta® Data Collection and Analysis
Completed
- Sickle Cell Disease
- Oxbryta® (voxelotor) 500-mg Tablets
-
Farmington, Connecticut
- +8 more
Sep 6, 2022
Sickle Cell Disease, Hemolytic Anemia Trial run by the NHLBI (Mitapivat)
Active, not recruiting
- Sickle Cell Disease
- Hemolytic Anemia
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Sickle Cell Disease Trial in Italy, United States (OTQ923, HIX763, OTQ923 or HIX763)
Recruiting
- Sickle Cell Disease
- OTQ923
-
Los Angeles, California
- +4 more
Jan 9, 2023
Study of the Role of Genetic Modifiers in Hemoglobinopathies
Recruiting
- Sickle Cell Disease
- +3 more
- GWAS
-
Boston, Massachusetts
- +24 more
Apr 4, 2023
Sickle Cell Disease Trial in United States (Oxbryta® (voxelotor) 500mg Tablets)
Recruiting
- Sickle Cell Disease
- Oxbryta® (voxelotor) 500mg Tablets
-
Palo Alto, California
- +9 more
Dec 15, 2022
Sickle Cell Disease (SCD) Trial in United States (crizanlizumab)
Active, not recruiting
- Sickle Cell Disease (SCD)
-
Orange City, Florida
- +11 more
Apr 25, 2022
GenoMed4ALL: Improving SCD Classification and Prognosis by AI
Recruiting
- Sickle Cell Disorders
-
Créteil, France
- +4 more
Aug 24, 2023
Sickle Cell Disease Trial in Chicago (Allogeneic Non-Myeloablative Stem Cell Transplantation, Alemtuzumab, Sirolimus)
Recruiting
- Sickle Cell Disease
- Allogeneic Non-Myeloablative Stem Cell Transplantation
- +2 more
-
Chicago, IllinoisUniversity of Illinois at Chicago
Feb 16, 2022
Sickle Cell Disease, Hyperbaric Oxygen Therapy, Vaso-occlusive Crisis Trial in Geneva (HBOT in Hyperbaric chamber, Hyperbaric
Recruiting
- Sickle Cell Disease
- +2 more
- HBOT in Hyperbaric chamber
- Hyperbaric chamber for placebo
-
Lyon, France
- +2 more
Nov 1, 2022
Kidney Function in Sickle Cell Anemia
Recruiting
- Sickle Cell Disease
- Kidney Failure, Chronic
-
Chapel Hill, North Carolina
- +2 more
Jun 11, 2021
Organic Erectile Dysfunction Trial in Guangzhou (Very small embryonic-like stem cell(VSEL))
Withdrawn
- Organic Erectile Dysfunction
- Very small embryonic-like stem cell(VSEL)
-
Guangzhou, Guangdong, ChinaCentral laboratory in Fuda cancer hospital
Oct 13, 2020